Company News for Mar 16, 2026
- Adobe Inc.’s (ADBE) shares tumbled 7.6%, after the company announced that its longtime CEO Shantanu Narayen will step down once a successor is appointed.
- Shares of Meta Platforms Inc. (META) slid 3.8% following news that the company has delayed the release of its new AI model "Avocado" to at least May.
- Shares of Nektar Therapeutics (NKTR) surged 4.1% after reporting fourth-quarter 2025 adjusted loss of $1.78 per share, narrower than the Zacks Consensus Estimate of an adjusted loss of $2.76 per share.
- Oruka Therapeutics Inc.’s (ORKA) shares soared 25% after posting fourth-quarter 2025 adjusted loss of $0.45 per share, narrower than the Zacks Consensus Estimate of an adjusted loss of $0.61 per share.
Zacks' Research Chief Picks Stock Most Likely to "At Least Double"
Our experts have revealed their Top 5 recommendations with money-doubling potential – and Director of Research Sheraz Mian believes one is superior to the others. Of course, all our picks aren’t winners but this one could far surpass earlier recommendations like Hims & Hers Health, which shot up +209%.
See Our Top Stock to Double (Plus 4 Runners Up) >>Adobe Inc. (ADBE) : Free Stock Analysis Report
Nektar Therapeutics (NKTR) : Free Stock Analysis Report
Meta Platforms, Inc. (META) : Free Stock Analysis Report
Oruka Therapeutics, Inc. (ORKA) : Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).
Zacks is the leading investment research firm focusing on stock research, analysis and recommendations. In 1978, our founder discovered the power of earnings estimate revisions to enable profitable investment decisions. Today, that discovery is still the heart of the Zacks Rank. A wealth of resources for individual investors is available at www.zacks.com.